Page last updated: 2024-09-05

sorafenib and l-779,450

sorafenib has been researched along with l-779,450 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(l-779,450)
Trials
(l-779,450)
Recent Studies (post-2010) (l-779,450)
6,5207305,25115011

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)l-779,450 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.0014
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.01

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandhuber, BJ; Buckmelter, AJ; Callejo, M; Grina, J; Laird, ER; Lyssikatos, J; Martinson, M; Miknis, G; Morales, T; Randolph, N; Rast, B; Ren, L; Schlachter, S; Tarlton, E; Vigers, G; Welch, M; Wenglowsky, S1

Other Studies

1 other study(ies) available for sorafenib and l-779,450

ArticleYear
The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors.
    Bioorganic & medicinal chemistry letters, 2011, Feb-15, Volume: 21, Issue:4

    Topics: Animals; Binding Sites; Cell Line, Tumor; Computer Simulation; Drug Evaluation, Preclinical; Humans; Indans; Microsomes, Liver; Models, Chemical; Models, Molecular; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridines; Rats; Structure-Activity Relationship

2011